Abiomed Europe GmbH

DER3101.HRB13059|Neuenhofer Weg 3, 52074 AachenGermany|2005

Profit€1.1M

Revenue€319.7M

Employees853

Balance€257.6M

About

Abiomed Europe GmbH is a leading medical technology manufacturer based in Aachen, specializing in the development, production, and distribution of circulatory support systems for interventional cardiology and cardiac surgery. The company serves as a central production site within the Abiomed group, which has been part of Johnson & Johnson since December 2022. Its core technology is based on the Impella platform, which is used globally as a minimally invasive mechanical circulatory support. The company primarily supplies cardiologists and surgeons in specialized laboratories and clinics.

Business purpose (commercial register)

Gegenstand des Unternehmens ist die Forschung und Entwicklung, die Herstellung, der Verkauf und das Marketing von Medizinprodukten und Medizingeräten, insbesondere zur Herz- und Kreislaufunterstützung, sowie die Beratung in verbundenen Geschäftsbereichen. Ausgenommen ist die Herstellung von Therapeutika und Diagnostika zum Zwecke der Abgabe an andere, soweit diese als Arzneimittel im Sinne des Arzneimittelgesetzes zu qualifizieren sind. Die Gesellschaft kann Filialen und/oder Tochtergesellschaften im In- und Ausland errichten sowie Beteiligungen eingehen.

ClassificationWZ 2025

C.32.50.3 - Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien a. n. g.

Business Sectors

Impella-Produkte313.590 TEUR(98.1%)

Medizinische Dienstleistungen6.107 TEUR(1.9%)

Products

Herzunterstützungssysteme Impella-Pumpsystem Katheter Kardiotechnik Medizinprodukte

Opportunities & Risks

Demografischer Wandel Innovation Wachstum Automatisierung Digitalisierung Robotik

Liquiditätsrisiken Währungsrisiken Projektrisiken Regulatorische Vorgaben Lieferketten Cyberangriff Rechtsstreitigkeiten Regulatorische Anforderungen

This summary was generated with the help of AI. See our Data Quality Notice. Report error?

Source: German Commercial Register (Handelsregister) Aachen Local Court, HRB 13059 (as of 29 September 2026)

Company Structure

Shareholders

Name	Type	City
Dirk Michels	Geschäftsführer(in)	Düsseldorf
Thorsten Sieß	Geschäftsführer(in)	Würselen

Source: German Commercial Register (Handelsregister) Aachen Local Court, HRB 13059 (as of 29 September 2026)

Company History

Management

Date	Event Type	Event
13.10.2023	Gesellschaftsvertrag amended	Gesellschaftsvertrag
13.04.2010	Business Address Registered	Neuenhofer Weg 3, 52074 Aachen
12.07.2006	Company Name Change	Abiomed Europe GmbH

Date	Type	Change	Total Capital
10.06.2005	Share Capital Set	—	1.292.150 €

CPV categories

Miscellaneous medical devices and products

Date	Contract	Role	Counterparty	Value
9.1.2025	Rahmenvereinbarung Intravaskuläre mikroaxiale Blutpumpe für die kardiologischen Abteilungen und In Supplier · NÖ Landesgesundheitsagentur	Supplier	NÖ Landesgesundheitsagentur	1.245.000 €

Source: German Commercial Register (Handelsregister) Aachen Local Court, HRB 13059 (as of 29 September 2026)

Financials

Key financial figures over time — Abiomed Europe GmbH
Year	Revenue	Profit	Balance	Employees
2024	€319,697,160	€1,098,478	€257,644,425	853
2023	€212,868,068	€13,791,467	€192,504,422	682
2022	€200,720,610	€22,695,518	€189,442,817	610
2021	€155,337,411	€20,019,371	€166,480,465	483
2020	€163,960,570	€11,207,180	€138,472,593	460
2019	€142,700,004	€21,059,779	€114,776,403	402
2018	€108,319,691	€18,835,289	€81,444,692	290
2017	€82,681,029	€12,232,668	€59,828,760	220
2016	€57,708,054	€10,808,877	€36,340,971	161
2015	€57,761,840	€5,644,892	€30,083,452	126

Source: German Company Register (Unternehmensregister)

Register Files

Current Printout (AD)

Chronological Printout (CD)

List of ShareholdersPublished on 11 December 2023

Articles of Association

Registration Application

Source: German Commercial Register (Handelsregister) Aachen Local Court, HRB 13059 (as of 29 September 2026)

Similar Companies

USSC Medical GmbH

Meerbusch · Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien a. n. g.

Stryker Trauma GmbH

Schönkirchen · Herstellung von orthopädischen Erzeugnissen

€255.2M

STRAUMANN GmbH

Freiburg im Breisgau · Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien a. n. g.

€274.6M

Annual Financial Statements

Annual Report 2024Published on 24 February 2026

Annual Report 2023Published on 11 July 2025

Annual Report 2023Published on 1 August 2024

Annual Report 2022Published on 25 April 2023

Annual Report 2021Published on 19 April 2022

Annual Report 2020Published on 5 July 2021

Annual Report 2019Published on 18 March 2020

Annual Report 2018Published on 11 April 2019

Annual Report 2017Published on 22 June 2018

Annual Report 2016Published on 25 September 2017

Annual Report 2015Published on 20 February 2017

Annual Report 2014Published on 13 May 2015

Annual Report 2013Published on 7 April 2014

Annual Report 2012Published on 15 April 2013

Annual Report 2011Published on 30 March 2012

Annual Report 2010Published on 31 March 2011

Annual Report 2009Published on 29 March 2010

Annual Report 2008Published on 30 March 2009

Annual Report 2007Published on 13 March 2008

Annual Report 2006Published on 28 December 2007

Source: German Company Register (Unternehmensregister)

Cost type	Amount	Share
Cost of Goods Sold	€7,324,620	49.0%
Selling Costs	€4,718,167	31.5%
Admin Costs	€2,912,601	19.5%

Abiomed Europe GmbH

About

Business purpose (commercial register)

ClassificationWZ 2025

Business Sectors

Products

Opportunities & Risks

Company Structure

Company History

Financials

Register Files

Similar Companies

Annual Financial Statements

Cost Distribution (2008)

Trends